Home › Funds › Sofinnova Investments, Inc. › BIOA
Sofinnova Investments, Inc. position in BIOA
BIOAGE LABS INC · Health Care
Sofinnova Investments, Inc. reported holding 2,293,788 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$56.2M, representing 3.00% of its reported portfolio and ranking #8 among its reported holdings. Sofinnova Investments, Inc. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s BIOA position evolved
Sofinnova Investments, Inc. first disclosed a stake in BIOA in Q3 2024 at 2,304,901 shares (US$47.9M). The position peaked in Q2 2026 at 2,293,788 shares, worth US$56.2M. Across 8 filings, Sofinnova Investments, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,293,788 shares valued at US$56.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.30M | $47.94M | New |
| Q4 2024 | 2.30M | $13.35M | Hold |
| Q1 2025 | 2.30M | $8.67M | Hold |
| Q2 2025 | 2.30M | $9.52M | Hold |
| Q3 2025 | 2.29M | $13.49M | Hold |
| Q4 2025 | 2.29M | $30.35M | Hold |
| Q1 2026 | 2.29M | $40.12M | Hold |
| Q2 2026 | 2.29M | $56.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIOA and 13F data
BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Octagon Capital Advisors LP (US$42.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIOA
- a16z Capital Management, L.L.C. 3.23M sh · $79.24M · Q2 2026
- Cormorant Asset Management, LP 2.39M sh · $58.59M · Q2 2026
- Octagon Capital Advisors LP 1.75M sh · $42.84M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.67M sh · $40.97M · Q2 2026
- MPM BioImpact LLC 1.67M sh · $40.87M · Q2 2026
- BRAIDWELL LP 1.03M sh · $25.32M · Q2 2026
- Sands Capital Alternatives, LLC 786.35K sh · $19.27M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 653.37K sh · $16.01M · Q2 2026
- Cosmic Management, LLC 501.83K sh · $12.30M · Q2 2026
- STEMPOINT CAPITAL LP 464.17K sh · $11.38M · Q2 2026
- Comprehensive Financial Management LLC 271.84K sh · $6.66M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 213.67K sh · $5.24M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held BIOA?
Sofinnova Investments, Inc. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Sofinnova Investments, Inc.'s current position in BIOA?
As of Q2 2026, Sofinnova Investments, Inc. holds 2.29M shares of BIOA (BIOAGE LABS INC), valued at $56.22M, representing 3.00% of its reported portfolio and ranking #8.
Has Sofinnova Investments, Inc. been buying or selling BIOA?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in BIOA. The position peaked in Q2 2026 at 2.29M shares.
Which other funds hold BIOA?
Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Octagon Capital Advisors LP, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.